Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns with SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R)
November 07 2007 - 8:30AM
PR Newswire (US)
LITTLE FALLS, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Cantel Medical
Corp. (NYSE:CMN), through its Crosstex subsidiary, a leading
provider of infection prevention and control products to the dental
and medical marketplace, reports significant interest from schools
for its hand sanitization and surface disinfectant products. Such
interest stems from the increase in reported incidences of MRSA
(Methicillin-resistant Staphylococcus aureus) skin infections.
According to R. Scott Jones, Cantel Medical's President & CEO,
"We are in contact with numerous school officials helping them
respond to the growing threat of MRSA and the need to address
concerns. They recognize the need for preventative measures against
the spread of MRSA and other infectious bacteria and viruses. While
school officials recognize that thorough hand washing remains the
most effective means of inhibiting the spread of germs, studies
show that less than half of middle and high school students wash
their hands for greater than five seconds. Waterless alcohol-based
hand sanitizers, such as Crosstex's SaniTyze(TM) brand, are
recommended by the Center for Disease Control (CDC) as an effective
method of hand hygiene." Jay McCann, a Board Member of the
Caldwell/West Caldwell, NJ school district says, "MRSA and other
infections are a big concern to students, parents and school
officials. We need to do all we can to prevent infection, and hand
hygiene is the single strongest recommendation we're hearing. We're
placing Crosstex waterless hand sanitizers in high-touch or high
risk areas, such as our sports field house, locker rooms and
cafeterias. Because it's fast and easy, we think the kids will use
it, and we'll improve overall hand hygiene in the schools."
According to the CDC, when MRSA skin infections occur, cleaning and
disinfection should be performed on surfaces that are likely to
contact uncovered or poorly covered infections. Our Sanitex(R) line
of surface disinfecting sprays and wipes are EPA listed as
effective against MRSA. Andrew G. Whitehead, Vice President of
Sales and Marketing at Crosstex, added, "With all the different
strains of bacteria and viruses out there, product claims against
those bugs can be confusing. Crosstex's waterless hand sanitizers
and surface disinfectants are listed by the EPA as effective
against a number of bacteria and viruses, including MRSA. Those
claims are clearly listed on the Crosstex website
(http://www.crosstex.com/)." He adds, "Crosstex products have held
significant market share in healthcare markets for a number of
years because of their high quality and efficacy. We are now
introducing them into other markets, such as schools and
businesses, as highly effective in meeting a growing public need."
Cantel Medical/Crosstex is offering free samples to school district
superintendents, nurses and business administrators. For inquiries
regarding products and services, please contact us at: or call Matt
Conlon at 973-890-7220. For more MRSA information, please refer to
the following websites: http://www.cdc.gov/features/MRSAinSchools/
http://www.cdc.gov/cleanhands/ About Crosstex International A
division of Cantel Medical Corp., Crosstex, founded in 1953, has
its headquarters and major manufacturing operations in Hauppauge,
New York. Sold throughout the world, Crosstex branded and private
label products include patient towels and bibs, sterilization
pouches and accessories, face masks, eyewear, disinfectants and
deodorizers, germicidal wipes, hand care products, gloves, sponges,
cotton products, needles and syringes, scalpels and blades,
containers, saliva evacuators and ejectors. For further
information, visit the Crosstex website at
http://www.crosstex.com/. About Cantel Medical Corp. Cantel Medical
Corp. (NYSE:CMN) is a leading provider of infection prevention and
control products in the healthcare market. Cantel's products
include specialized medical device reprocessing systems for renal
dialysis and endoscopy, dialysate concentrates and other dialysis
supplies, disposable infection control products primarily for the
dental industry, water purification equipment, sterilants,
disinfectants and cleaners, hollow fiber membrane filtration and
separation products for medical and non-medical applications, and
specialty packaging for infectious and biological specimens. Cantel
also provides technical maintenance for its products and offers
compliance training services for the transport of infectious and
biological specimens. For further information, visit the Cantel
website at http://www.cantelmedical.com/. DATASOURCE: Cantel
Medical Corp. CONTACT: R. Scott Jones, President and CEO, or Matt
Conlon, Vice President, Market Development, , both of Cantel
Medical Corp., +1-973-890-7220 Web site: http://www.crosstex.com/
http://www.cantelmedical.com/
http://www.cdc.gov/features/MRSAinSchools
http://www.cdc.gov/cleanhands
Copyright
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024